PUBLISHER: The Business Research Company | PRODUCT CODE: 2127540
PUBLISHER: The Business Research Company | PRODUCT CODE: 2127540
Proton therapy centers or high-capacity cyclotrons are advanced radiation treatment systems that employ high-energy particle accelerators, including cyclotrons and synchrotrons, to propel protons to near-light speeds for highly precise cancer treatment. By utilizing the Bragg Peak effect, proton therapy concentrates the highest radiation dose directly within tumors while reducing exposure to surrounding healthy tissues, making it especially beneficial for treating deep-seated, pediatric, and anatomically challenging cancers with greater precision and fewer side effects.
The primary product categories of proton therapy centers or high-capacity cyclotrons include cyclotron-based proton therapy systems, synchrotron-based proton therapy systems, compact proton therapy systems, and multi-room proton therapy systems. Cyclotron-based proton therapy systems are advanced radiation therapy platforms that produce high-energy proton beams through cyclotrons to accurately target tumors while reducing radiation exposure to surrounding healthy tissues. These systems are available as multi-room treatment centers, single-room compact systems, fixed beam line rooms, and rotating gantry rooms, and they support treatment delivery methods including pencil beam scanning and passive scattering beam delivery. Their applications include pediatric cancer, head and neck cancer, brain and central nervous system tumors, prostate cancer, lung cancer, breast cancer, re-irradiation, and other conditions, and they are utilized by specialized cancer centers, academic and university hospitals, multi-specialty hospitals, dedicated proton therapy centers, and other healthcare providers.
Tariffs are influencing the proton therapy centers or high-capacity cyclotrons market by increasing expenses for imported cyclotrons, synchrotrons, superconducting magnets, rotating gantries, beam delivery systems, and precision radiation therapy components. This is delaying the establishment of new proton therapy centers and increasing installation expenditures, particularly in regions dependent on imported medical equipment such as Asia-Pacific and Latin America. Equipment-intensive categories including cyclotron-based proton therapy systems, synchrotron-based proton therapy systems, compact proton therapy systems, and multi-room proton therapy systems are experiencing the greatest impact because of global supply chain dependence. Nevertheless, tariffs are encouraging domestic manufacturing, regional supplier diversification, and greater investment in local medical technology production, supporting stronger long-term resilience across the market.
The proton therapy centers or high-capacity cyclotrons market research report is one of a series of new reports from The Business Research Company that provides proton therapy centers or high-capacity cyclotrons market statistics, including proton therapy centers or high-capacity cyclotrons industry global market size, regional shares, competitors with a proton therapy centers or high-capacity cyclotrons market share, detailed proton therapy centers or high-capacity cyclotrons market segments, market trends and opportunities, and any further data you may need to thrive in the proton therapy centers or high-capacity cyclotrons industry. This proton therapy centers or high-capacity cyclotrons market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The proton therapy centers or high-capacity cyclotrons market size has grown rapidly in recent years. It will grow from $1 billion in 2025 to $1.1 billion in 2026 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to growing incidence of cancer worldwide, increasing adoption of advanced radiation therapy, rising demand for precision oncology treatments, expanding investments in cancer treatment infrastructure, growing awareness of reduced radiation related side effects.
The proton therapy centers or high-capacity cyclotrons market size is expected to see rapid growth in the next few years. It will grow to $1.65 billion in 2030 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to increasing establishment of proton therapy centers, rising healthcare expenditure on oncology care, expanding reimbursement support for proton therapy, growing demand for treatment of complex tumors, increasing public and private investments in particle therapy facilities. Major trends in the forecast period include growing adoption of pencil beam scanning technology, increasing installation of compact single room proton therapy systems, rising demand for pediatric cancer focused proton therapy, expansion of multi room proton therapy treatment centers, growing preference for organ sparing radiation therapy.
The growing demand for precision radiation therapy is expected to drive the growth of the proton therapy centers or high-capacity cyclotrons market in the coming years. Precision radiation therapy is an advanced cancer treatment approach that delivers targeted radiation doses to tumors while limiting radiation exposure to surrounding healthy tissues. The increasing demand for precision radiation therapy is fueled by the rising incidence of cancer, growing preference for minimally invasive treatment alternatives, and ongoing technological advancements in radiation oncology. Proton therapy centers and high-capacity cyclotrons support the generation of high-energy proton beams needed for accurate tumor targeting, enhancing treatment precision, minimizing side effects, and improving clinical outcomes for cancer patients. For instance, in December 2024, according to ScienceDirect, a Netherlands-based online platform, global demand for radiotherapy is expected to increase to approximately 21.2 million patients by 2050, assuming a 64% radiotherapy utilization rate, representing a significant rise compared with the number of patients treated in 2022. Therefore, the increasing demand for precision radiation therapy is contributing to the growth of the proton therapy centers or high-capacity cyclotrons market.
Leading companies operating in the proton therapy centers or high-capacity cyclotrons market are focusing on developing compact proton therapy systems to improve treatment precision, reduce installation complexity, and expand access to advanced cancer care. Compact proton therapy systems refer to space-efficient proton beam therapy solutions that combine advanced accelerator technologies, imaging systems, and treatment planning capabilities to deliver highly targeted radiation while minimizing exposure to surrounding healthy tissues. For example, in May 2024, IBA (Ion Beam Applications), a Belgium-based provider of proton therapy solutions, signed a contract with Yale New Haven Health and Hartford HealthCare to install its ProteusONE compact proton therapy system in Connecticut, US. The system integrates advanced pencil beam scanning technology and is designed to be upgradeable with DynamicARC beam delivery capabilities after obtaining regulatory clearance. Its compact single-room design, intelligent treatment planning, and precision beam control enable highly accurate cancer treatment while improving clinical workflow and expanding patient access to proton therapy. By combining compact system architecture with advanced proton beam technologies, Proteus(R)ONE represents an innovative approach to precision radiation therapy.
In September 2024, Mevion Medical Systems Inc., a US-based medical equipment manufacturer, collaborated with NELCO Worldwide to improve proton therapy implementation. The partnership supported the wider adoption of proton therapy by allowing existing linear accelerator (LINAC) treatment vaults to be effectively adapted for the installation of compact proton therapy systems. By integrating advanced radiation shielding technologies with streamlined vault modification solutions, the collaboration enabled healthcare providers to lower deployment timelines and infrastructure expenses while increasing access to proton therapy. NELCO Worldwide is a US-based company specializing in radiation shielding solutions.
Major companies operating in the proton therapy centers or high-capacity cyclotrons market report are Hitachi Ltd., Mitsubishi Electric Corporation, Ion Beam Applications S.A. (IBA), Sumitomo Heavy Industries Ltd., Shinva Medical Instrument Co. Ltd., Mevion Medical Systems Inc., ProTom International Holding Corp., Advanced Cyclotron Systems Inc., Optivus Proton Therapy Inc., Leo Cancer Care, Best Cyclotron Systems Inc., China Institute of Atomic Energy, B dot Medical Inc.
North America was the dominant region in the proton therapy centers or high-capacity cyclotrons market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the proton therapy centers or high-capacity cyclotrons market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the proton therapy centers or high-capacity cyclotrons market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The proton therapy centers or high-capacity cyclotrons market consists of revenues earned by entities by providing services such as treatment planning, patient positioning, imaging and motion management, quality assurance, and proton therapy treatment services. The market value includes the value of related goods sold by the service provider or included within the service offering. The proton therapy centers or high-capacity cyclotrons market also includes sales of particle accelerators, superconducting magnets, beam transport systems, nozzle systems, and imaging equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Proton Therapy Centers Or High-Capacity Cyclotrons Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses proton therapy centers or high-capacity cyclotrons market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for proton therapy centers or high-capacity cyclotrons ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The proton therapy centers or high-capacity cyclotrons market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.